Company overview
Nanoworx B.V. is a Netherlands-based Contract Research Organization specializing in nanomedicine development for pharmaceutical and biotech clients. They offer nanoparticle design and prototyping, high-throughput library construction and screening, scaled production, and in vitro assay testing. These customizable services support all stages of nanomedicine advancement, from early design to optimization.
Nanoworx - Home is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include nanomedicine cro, nanoparticle design, nanomedicine screening, nanoparticle production, in vitro assays.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Nanoworx - Home include Assay, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://nanoworx.nl
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- nanomedicine cro, nanoparticle design, nanomedicine screening, nanoparticle production, in vitro assays
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What nanomedicine services does Nanoworx provide?
- Nanoworx offers nanoparticle design and prototyping, high-throughput library construction and screening, nanomedicine production at scale, and in vitro assay testing, all customizable for client needs.
- Where is Nanoworx located and what is their expertise?
- Based in Eindhoven, Netherlands, Nanoworx leverages state-of-the-art equipment and expertise in nanomedicine design, prototyping, library optimization, and scaling for academic and industry partners.
- What stages of development does Nanoworx support?
- Services cover the full spectrum from early exploration and prototyping to advanced platform optimization, high-throughput screening, and scaled production.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
